These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 7149441

  • 1. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia.
    Jakab GJ.
    Am Rev Respir Dis; 1982 Nov; 126(5):778-82. PubMed ID: 7149441
    [Abstract] [Full Text] [Related]

  • 2. The participation of antiviral immune mechanisms in alveolar macrophage dysfunction during viral pneumonia.
    Jakab GJ, Warr GA.
    Bull Eur Physiopathol Respir; 1983 Nov; 19(2):173-8. PubMed ID: 6871495
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary antibacterial defenses during mild and severe influenza virus infection.
    Nickerson CL, Jakab GJ.
    Infect Immun; 1990 Sep; 58(9):2809-14. PubMed ID: 2143751
    [Abstract] [Full Text] [Related]

  • 4. Staphylococcal clearance and pulmonary macrophage function during influenza infection.
    Nugent KM, Pesanti EL.
    Infect Immun; 1982 Dec; 38(3):1256-62. PubMed ID: 7152668
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.
    Small CL, Shaler CR, McCormick S, Jeyanathan M, Damjanovic D, Brown EG, Arck P, Jordana M, Kaushic C, Ashkar AA, Xing Z.
    J Immunol; 2010 Feb 15; 184(4):2048-56. PubMed ID: 20083661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis.
    Narasaraju T, Ng HH, Phoon MC, Chow VT.
    Am J Respir Cell Mol Biol; 2010 Jun 15; 42(6):732-43. PubMed ID: 19617401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alveolitis induced by influenza virus.
    Jakab GJ, Astry CL, Warr GA.
    Am Rev Respir Dis; 1983 Oct 15; 128(4):730-9. PubMed ID: 6625351
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of prior influenza infection on alveolar macrophage phagocytosis of Staphylococcus aureus and Escherichia coli: involvement of interferon-gamma production.
    Hang do TT, Choi EJ, Song JY, Kim SE, Kwak J, Shin YK.
    Microbiol Immunol; 2011 Nov 15; 55(11):751-9. PubMed ID: 21895747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.
    van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LM.
    Am J Respir Cell Mol Biol; 1990 Jan 15; 2(1):91-8. PubMed ID: 2306370
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of phagocytosis of Staphylococcus aureus by alveolar and peritoneal macrophages.
    Pesanti EL.
    Infect Immun; 1979 Nov 15; 26(2):479-86. PubMed ID: 546784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.